Retinoblastoma Tumor Suppressor Protein in Pancreatic Progenitors Controls Α- and Β-Cell Fate

Total Page:16

File Type:pdf, Size:1020Kb

Retinoblastoma Tumor Suppressor Protein in Pancreatic Progenitors Controls Α- and Β-Cell Fate Retinoblastoma tumor suppressor protein in pancreatic progenitors controls α- and β-cell fate Erica P. Caia,b, Xiaohong Wuc, Stephanie A. Schroera, Andrew J. Eliad,e, M. Cristina Nostroa,f, Eldad Zacksenhausa, and Minna Wooa,b,e,g,1 aToronto General Research Institute and fMcEwen Centre for Regenerative Medicine, University Health Network, Toronto, ON, Canada M5G 1L7; bInstitute of Medical Science, University of Toronto, Toronto, ON, Canada M5S 1A8; cThe First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China; dCampbell Family Institute for Breast Cancer Research, University Health Network, Toronto, ON, Canada M5G 2M9; eDepartment of Medical Biophysics, University of Toronto, Toronto, ON, Canada M5G 2M9; and gDivision of Endocrinology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada M5G 2C4 Edited by Tak W. Mak, The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada, and approved July 16, 2013 (received for review February 20, 2013) Pancreatic endocrine cells expand rapidly during embryogenesis apoptosis (15), in a highly cell-specific and context-dependent by neogenesis and proliferation, but during adulthood, islet cells manner (16, 17). Although Rb is critical in regulating cell cycle have a very slow turnover. Disruption of murine retinoblastoma entry in proliferating cells, its role in postmitotic cells is more tumor suppressor protein (Rb) in mature pancreatic β-cells has limited. For example, Rb deficiency in proliferating myoblasts a limited effect on cell proliferation. Here we show that deletion induces increased proliferation and apoptosis (18), whereas fi fi of Rb during embryogenesis in islet progenitors leads to an in- Rb de ciency in postmitotic muscle bers does not lead to any crease in the neurogenin 3-expressing precursor cell population, defects (19). Rb has also been shown to control cell lineage which persists in the postnatal period and is associated with in- commitment in several cell types, including mesenchymal stem cells (20) and preadipocytes (21). In the pancreas, Rb has been creased β-cell mass in adults. In contrast, Rb-deficient islet precur- shown to play a minor role in well-differentiated β-cells, as evi- sors, through repression of the cell fate factor aristaless related denced by mice with rat insulin promoter-Cre-driven Rb deletion homeobox, result in decreased α-cell mass. The opposing effect on fi α β (22). However, E2f1 is required for normal pancreatic islet func- survival of Rb-de cient - and -cells was a result of opposing tion and homeostasis (23, 24). E2f1 directly regulates insulin se- effects on p53 in these cell types. As a consequence, loss of Rb cretion through modulating inward rectifier potassium channel in islet precursors led to a reduced α-toβ-cell ratio, leading to Kir6.2 expression (25). Although these results suggest a role for improved glucose homeostasis and protection against diabetes. Rb in islet development and function, the effect of Rb disruption in proliferating islet precursors is unknown. diabetes mellitus | insulin | glucagon | cell cycle | E2f To address this issue, we deleted Rb in Pdx1-expressing pan- creatic progenitors. Remarkably, as opposed to the minor effect β ancreatic α- and β-cells control glucose homeostasis through of Rb deletion in postmitotic -cells, disruption of Rb in pan- glucagon and insulin, which have opposing effects (1). The creatic progenitors had a profound effect on both pancreatic P α β fi pancreatic islet cell mass is achieved through a rapid surge of -and -cell fates. Rb de ciency led to increased Ngn3 and neu- neogenesis and proliferation that occurs during the perinatal rogenic differentiation 1 (NeuroD1) expression in islets, which fi period (2). However, this plasticity declines significantly in the represent multipotent endocrine islet cells. These Rb-de cient β postnatal period (3), resulting in a limited ability of islets to re- precursors showed enhanced -cell differentiation during em- generate in adulthood (4). However, molecular mechanisms that bryogenesis. Furthermore, Ngn3 expression persisted postnatally fi β govern both neogenesis and proliferation in islet cells remain in Rb-de cient islets, which were associated with increased -cell fi elusive. Better understanding of these processes may allow for mass. In contrast, Rb-de cient islet precursors failed to differ- α α the development of therapeutic strategies to treat diabetes. entiate into mature -cells because of the repression of an -cell During embryogenesis, the pancreas develops from foregut developmental gene, aristaless related homeobox (Arx), resulting α α β endoderm progenitors, which start expressing pancreatic and in a reduced -cell mass. These opposing effects on - and -cell duodenal homeobox 1 (Pdx1) at embryonic day 8.5 (E8.5) (5). differentiation and survival resulting from Rb loss led to improved Islet endocrine cells derive from neurogenin 3 (Ngn3)-expressing glucose homeostasis and protection against diabetes. precursors located in the pancreatic epithelium at E8.75 (6). α Results Once islet precursors adopt a cell identity by producing -or fi β β-cell hormones, these cells become postmitotic, after which only Rb De ciency in Islet Precursors Promotes -Cell Fate Through a limited number (<10%) of differentiated cells can reenter the Differentiation and Neogenesis. To investigate the physiologic cell cycle and contribute to prenatal islet expansion (7, 8). Neo- role of Rb in regulating islet cell fate, we deleted Rb in Pdx1- expressing pancreatic progenitor cells, using the Cre-loxP re- genesis, a proliferation process of undifferentiated precursors, is + fl fl combination system (26), yielding Pdx1-Cre Rb / mice, denoted the main mode through which rapid islet expansion is achieved fi in the late phase of fetal development (2). However, neogenesis herein as pancreas-speci c Rb knockout (p-RbKO) mice (Fig. S1A). To elucidate whether Rb is involved in regulating islet cell declines rapidly in the postnatal period, and Ngn3-expressing fi islet precursor cells become virtually absent by age 1 wk in mice differentiation, we rst examined the islet cell population in fetal (9, 10). Thereafter, the majority of islets are maintained in a pancreas at E16.5, when multipotent islet precursors are developing noncycling state without the ability to readily self-replicate. into single-hormone-expressing differentiated endocrine cells. The retinoblastoma tumor suppressor protein (Rb) functions MEDICAL SCIENCES as a major gatekeeper of cell cycle progression from G1 to S phase and is required for maintaining cells in the noncycling, Author contributions: E.P.C., M.C.N., E.Z., and M.W. designed research; E.P.C., X.W., S.A.S., quiescent stage (11). Rb inhibits cell cycle progression by binding and A.J.E. performed research; A.J.E., M.C.N., E.Z., and M.W. contributed new reagents/ to transcription factors such as E2f transcription factor 1 (E2f1) analytic tools; E.P.C. analyzed data; and E.P.C., M.C.N., E.Z., and M.W. wrote the paper. and inhibiting their transactivation (11). Rb phosphorylation The authors declare no conflict of interest. leads to its dissociation from E2f and the transcription of E2f- This article is a PNAS Direct Submission. regulated genes that are required for S phase entry (12). In ad- 1To whom correspondence should be addressed. E-mail: [email protected]. dition to cell cycle regulation, Rb controls multiple other cellular This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. processes, including differentiation (13), senescence (14), and 1073/pnas.1303386110/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1303386110 PNAS | September 3, 2013 | vol. 110 | no. 36 | 14723–14728 Downloaded by guest on September 27, 2021 Intriguingly, we observed an increase in Ngn3 expression in islets Expression of Ngn3 persisted postnatally up to 4 wk of age in of p-RbKO pancreata at E16.5 compared with littermate con- p-RbKO mice compared with littermate controls (Fig. 1 B and C trols (Fig. 1A and Fig. S1B). The increase in this key determinant and Table S1). Consistent with this gene expression profile, – of endocrine lineage was observed along with another critical Ngn3-expressing islet cells were present in 4 8-wk-old p-RbKO downstream islet differentiation factor, NeuroD1 (Fig. 1A and mice, and these cells coexpressed insulin (Fig. 1D and Fig. S1C). These results suggest that Rb in islet precursors plays a critical Fig. S1B). To examine development into β-cell lineage, we next + role in regulating Ngn3 expression, and the preserved Ngn3 cell assessed for β-cell differentiation markers, NK6 homeobox 1 β fi population is capable of differentiating into mature -cells in the (Nkx6.1) and musculoaponeurotic brosarcoma oncogene family absence of Rb. proteins A (MafA), which were also increased (Fig. 1A and Fig. Ngn3 can activate downstream homeodomain-containing tran- S1B). All of these developmental markers also had a high pro- scription factor, paired box 4 (Pax4) (27), which can act as a portion of cells that coexpressed insulin (Fig. 1A and Fig. S1B), repressor of Arx; together, they mediate proper endocrine islet which together indicated that Rb deficiency in pancreatic pro- cell specification (28). Consistent with the findings in fetal p-RbKO genitors led to an increase in the number of endocrine precursors pancreas, the increased Ngn3 level was associated with a significant and enhanced differentiation into β-cells. induction of Pax4 expression in neonatal p-RbKO pancreas (Fig. 1E). In addition, expression of Pdx1 and MafA, which are also re- quired for β-cell specification, were significantly elevated (Fig. 1E). In keeping with these increases in β-cell neogenesis and differ- A BC entiation markers, p-RbKO pancreata exhibited an increase in Glu Ins Merge Control single or small clusters of insulin-expressing cells in close proximity p-RbKO to pancreatic ducts (Fig.
Recommended publications
  • Roles and Regulation of Transcription Factor Mafa in Islet Β-Cells
    Endocr. J./ S. ARAMATA et al.: INSULIN TRANSCRIPTION AND MafA doi: 10.1507/endocrj.KR-101 REVIEW Roles and Regulation of Transcription Factor MafA in Islet β-cells * SHINSAKU ARAMATA, SONG-IEE HAN AND KOHSUKE KATAOKA Graduate School of Biological Science, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma, Nara 630-0192, Japan *Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba Science City, Ibaraki 305-8572, Japan. Released online August 30, 2007 Correspondence to: Kohsuke KATAOKA, Graduate School of Biological Science, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma, Nara 630-0192, Japan Abstract. Insulin is a critical hormone in the regulation of blood glucose levels. It is produced exclusively by pancreatic islet β-cells. β-cell-enriched transcription factors, such as Pdx1 and Beta2, have dual roles in the activation of the insulin gene promoter establishing β-cell-specific insulin expression, and in the regulation of β-cell differentiation. It was shown that MafA, a β-cell-specific member of the Maf family of transcription factors, binds to the conserved C1/RIPE3b element of the insulin promoter. The Maf family proteins regulate tissue-specific gene expression and cell differentiation in a wide variety of tissues. MafA acts synergistically with Pdx1 and Beta2 to activate the insulin gene promoter, and mice with a targeted deletion of mafA develop age-dependent diabetes. MafA also regulates genes involved in β-cell function such as Glucose transporter 2, Glucagons-like peptide 1 receptor, and Prohormone convertase 1/3. The abundance of MafA in β-cells is regulated at both the transcriptional and post-translational levels by glucose and oxidative stress.
    [Show full text]
  • Modeling the Phenotype of Spinal Muscular Atrophy by the Direct Conversion of Human Fibroblasts to Motor Neurons
    www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 7), pp: 10945-10953 Research Paper Modeling the phenotype of spinal muscular atrophy by the direct conversion of human fibroblasts to motor neurons Qi-Jie Zhang1,*, Jin-Jing Li1,*, Xiang Lin1, Ying-Qian Lu1, Xin-Xin Guo1, En-Lin Dong1, Miao Zhao1, Jin He1, Ning Wang1,2 and Wan-Jin Chen1,2 1 Department of Neurology and Institute of Neurology, First Affiliated Hospital, Fujian Medical University, Fuzhou, China 2 Fujian Key Laboratory of Molecular Neurology, Fuzhou, China * These authors have contributed equally to this work Correspondence to: Wan-Jin Chen, email: [email protected] Keywords: direct reprogramming; fibroblast; induced motor neuron; spinal muscular atrophy Received: June 08, 2016 Accepted: November 22, 2016 Published: January 13, 2017 ABSTRACT Spinal muscular atrophy (SMA) is a lethal autosomal recessive neurological disease characterized by selective degeneration of motor neurons in the spinal cord. In recent years, the development of cellular reprogramming technology has provided an alternative and effective method for obtaining patient-specific neuronsin vitro. In the present study, we applied this technology to the field of SMA to acquire patient- specific induced motor neurons that were directly converted from fibroblasts via the forced expression of 8 defined transcription factors. The infected fibroblasts began to grow in a dipolar manner, and the nuclei gradually enlarged. Typical Tuj1-positive neurons were generated at day 23. After day 35, induced neurons with multiple neurites were observed, and these neurons also expressed the hallmarks of Tuj1, HB9, ISL1 and CHAT. The conversion efficiencies were approximately 5.8% and 5.5% in the SMA and control groups, respectively.
    [Show full text]
  • Rb and P53 Execute Distinct Roles in the Development of Pancreatic Neuroendocrine Tumors
    Author Manuscript Published OnlineFirst on June 26, 2020; DOI: 10.1158/0008-5472.CAN-19-2232 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 1 Title: Rb and p53 execute distinct roles in the development of pancreatic neuroendocrine tumors 2 Running Title: Roles of Rb and p53 in pancreatic neuroendocrine tumors 3 4 1Yuki Yamauchi, 1,2Yuzo Kodama, 1Masahiro Shiokawa, 1Nobuyuki Kakiuchi, 1Saiko Marui, 5 1Takeshi Kuwada, 1Yuko Sogabe, 1Teruko Tomono, 1Atsushi Mima, 1Toshihiro Morita, 1Tomoaki 6 Matsumori, 1Tatsuki Ueda, 1Motoyuki Tsuda, 1Yoshihiro Nishikawa, 1Katsutoshi Kuriyama, 7 1Yojiro Sakuma, 1Yuji Ota, 1Takahisa Maruno, 1Norimitsu Uza, 2Atsuhiro Masuda, 3Hisato 8 Tatsuoka, 3Daisuke Yabe, 4Sachiko Minamiguchi, 5Toshihiko Masui, 3Nobuya Inagaki, 5Shinji 9 Uemoto, 1,6Tsutomu Chiba, and 1Hiroshi Seno 10 11 1Department of Gastroenterology and Hepatology, Kyoto University Graduate School of 12 Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 13 2Department of Gastroenterology, Kobe University Graduate School of Medicine, 7-5-1 14 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. 15 3Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of 16 Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 17 4Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, 54 18 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 1 Downloaded from cancerres.aacrjournals.org on September 28, 2021. © 2020 American Association for Cancer Research. Author Manuscript Published OnlineFirst on June 26, 2020; DOI: 10.1158/0008-5472.CAN-19-2232 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
    [Show full text]
  • Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes
    Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes Sevda Gheibi *, Tania Singh, Joao Paulo M.C.M. da Cunha, Malin Fex and Hindrik Mulder * Unit of Molecular Metabolism, Lund University Diabetes Centre, Jan Waldenströms gata 35; Box 50332, SE-202 13 Malmö, Sweden; [email protected] (T.S.); [email protected] (J.P.M.C.M.d.C.); [email protected] (M.F.) * Correspondence: [email protected] (S.G.); [email protected] (H.M.) Supplementary Table 1. Transcription factors associated with development of the pancreas. Developmental Gene Aliases Function Ref. Stage SRY-Box Transcription Factor Directs the primitive endoderm SOX17 DE, PFE, PSE [1] 17 specification. Establishes lineage-specific transcriptional programs which leads DE, PFE, PSE, Forkhead Box A2; Hepatocyte to proper differentiation of stem cells FOXA2 PMPs, EPs, [2] Nuclear Factor 3-β into pancreatic progenitors. Regulates Mature β-cells expression of PDX1 gene and aids in maturation of β-cells A pleiotropic developmental gene which regulates growth, and Sonic Hedgehog Signaling differentiation of several organs. SHH DE [3] Molecule Repression of SHH expression is vital for pancreas differentiation and development Promotes cell differentiation, proliferation, and survival. Controls C-X-C Motif Chemokine the spatiotemporal migration of the Receptor 4; Stromal Cell- CXCR4 DE angioblasts towards pre-pancreatic [4] Derived Factor 1 Receptor; endodermal region which aids the Neuropeptide Y3 Receptor induction of PDX1 expression giving rise to common pancreatic progenitors Crucial for generation of pancreatic HNF1 Homeobox B HNF1B PFE, PSE, PMPs multipotent progenitor cells and [5] Hepatocyte Nuclear Factor 1-β NGN3+ endocrine progenitors Master regulator of pancreatic organogenesis.
    [Show full text]
  • Regulation of Adult Neurogenesis in Mammalian Brain
    International Journal of Molecular Sciences Review Regulation of Adult Neurogenesis in Mammalian Brain 1,2, 3, 3,4 Maria Victoria Niklison-Chirou y, Massimiliano Agostini y, Ivano Amelio and Gerry Melino 3,* 1 Centre for Therapeutic Innovation (CTI-Bath), Department of Pharmacy & Pharmacology, University of Bath, Bath BA2 7AY, UK; [email protected] 2 Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK 3 Department of Experimental Medicine, TOR, University of Rome “Tor Vergata”, 00133 Rome, Italy; [email protected] (M.A.); [email protected] (I.A.) 4 School of Life Sciences, University of Nottingham, Nottingham NG7 2HU, UK * Correspondence: [email protected] These authors contributed equally to this work. y Received: 18 May 2020; Accepted: 7 July 2020; Published: 9 July 2020 Abstract: Adult neurogenesis is a multistage process by which neurons are generated and integrated into existing neuronal circuits. In the adult brain, neurogenesis is mainly localized in two specialized niches, the subgranular zone (SGZ) of the dentate gyrus and the subventricular zone (SVZ) adjacent to the lateral ventricles. Neurogenesis plays a fundamental role in postnatal brain, where it is required for neuronal plasticity. Moreover, perturbation of adult neurogenesis contributes to several human diseases, including cognitive impairment and neurodegenerative diseases. The interplay between extrinsic and intrinsic factors is fundamental in regulating neurogenesis. Over the past decades, several studies on intrinsic pathways, including transcription factors, have highlighted their fundamental role in regulating every stage of neurogenesis. However, it is likely that transcriptional regulation is part of a more sophisticated regulatory network, which includes epigenetic modifications, non-coding RNAs and metabolic pathways.
    [Show full text]
  • E Proteins and ID Proteins: Helix-Loop-Helix Partners in Development and Disease
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Developmental Cell Review E Proteins and ID Proteins: Helix-Loop-Helix Partners in Development and Disease Lan-Hsin Wang1 and Nicholas E. Baker1,2,3,* 1Department of Genetics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA 2Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA 3Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA *Correspondence: [email protected] http://dx.doi.org/10.1016/j.devcel.2015.10.019 The basic Helix-Loop-Helix (bHLH) proteins represent a well-known class of transcriptional regulators. Many bHLH proteins act as heterodimers with members of a class of ubiquitous partners, the E proteins. A widely expressed class of inhibitory heterodimer partners—the Inhibitor of DNA-binding (ID) proteins—also exists. Genetic and molecular analyses in humans and in knockout mice implicate E proteins and ID proteins in a wide variety of diseases, belying the notion that they are non-specific partner proteins. Here, we explore relationships of E proteins and ID proteins to a variety of disease processes and highlight gaps in knowledge of disease mechanisms. E proteins and Inhibitor of DNA-binding (ID) proteins are widely conferring DNA-binding specificity and transcriptional activation expressed transcriptional regulators with very general functions. on heterodimers with the ubiquitous E proteins (Figure 1). They are implicated in diseases by evidence ranging from Another class of pervasive HLH proteins acts in opposition to confirmed Mendelian inheritance, association studies, and E proteins.
    [Show full text]
  • The Role of Hes1 in Pancreas Development Expression, Interdependancy and Notch Signalling
    FACULTY OF SCIENCE UNIVERSITY OF COPENHAGEN PhD thesis Cand.scient. Rasmus Klinck Department of Beta Cell Regeneration, Hagedorn Research Institute, and The PhD School of Science, Faculty of Science, University of Copenhagen, Denmark. The role of Hes1 in pancreas development Expression, Interdependancy and Notch signalling. Academic Advisors Dr. Olaf Nielsen, Department of Biology, Faculty of Science, University of Copenhagen – Denmark Dr. Mette C. Jørgensen, Department of Beta Cell Regeneration, Hagedorn Research Institute Denmark Submitted: 31/05/11 Cover picture: e10.5 mouse embryo expressing EGFP under the control of the Hes1 promoter manually stitched together from 15 complete image stacks. 2 Preface This Ph.D. thesis is based on experimental work performed in the Department of β Cell Regeneration at the Hagedorn Research Institute, Gentofte, Denmark from January 2008 to December 2010. The faculty supervisor on the project was Professor Olaf Nielsen, Department of Genetics, Faculty of Science, University of Copenhagen, and the project supervisor was Mette Christine Jørgensen, Ph.D., Chemist, Department of Beta Cell Regeneration at the Hagedorn Research Institute. This thesis is submitted in order to meet the requirements for obtaining a Ph.D. degree at the Faculty of Science, University of Copenhagen. The thesis is built around three scientific Manuscripts: Manuscript I: “A BAC transgenic Hes1-EGFP reporter reveals novel expression domains in mouse embryos” Submitted to Gene Expression Patterns Rasmus Klinck1, Ernst-Martin Füchtbauer2, Jonas Ahnfelt-Rønne1, Palle Serup1,Jan Nygaard Jensen1, Ole Dragsbæk Madsen1, Mette Christine Jørgensen1 1Department of Beta Cell Regeneration, Hagedorn Research Institute, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark .2Department of Molecular Biology, Aarhus University, C.
    [Show full text]
  • Genome-Wide DNA Methylation Analysis Reveals Molecular Subtypes of Pancreatic Cancer
    www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 17), pp: 28990-29012 Research Paper Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer Nitish Kumar Mishra1 and Chittibabu Guda1,2,3,4 1Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, 68198, USA 2Bioinformatics and Systems Biology Core, University of Nebraska Medical Center, Omaha, NE, 68198, USA 3Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA 4Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA Correspondence to: Chittibabu Guda, email: [email protected] Keywords: TCGA, pancreatic cancer, differential methylation, integrative analysis, molecular subtypes Received: October 20, 2016 Accepted: February 12, 2017 Published: March 07, 2017 Copyright: Mishra et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Pancreatic cancer (PC) is the fourth leading cause of cancer deaths in the United States with a five-year patient survival rate of only 6%. Early detection and treatment of this disease is hampered due to lack of reliable diagnostic and prognostic markers. Recent studies have shown that dynamic changes in the global DNA methylation and gene expression patterns play key roles in the PC development; hence, provide valuable insights for better understanding the initiation and progression of PC. In the current study, we used DNA methylation, gene expression, copy number, mutational and clinical data from pancreatic patients.
    [Show full text]
  • Lineage Transcription Factors Co-Regulate Subtype-Specific Genes Providing a Roadmap For
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.13.249029; this version posted August 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Lineage transcription factors co-regulate subtype-specific genes providing a roadmap for systematic identification of small cell lung cancer vulnerabilities Karine Pozo1,2, Rahul K. Kollipara3, Demetra P. Kelenis1, Kathia E. Rodarte1, Xiaoyang Zhang4, John D. Minna5,6,7,8 and Jane E. Johnson1,6,8 1Department of Neuroscience, 2Department of Surgery, 3McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX 75390, USA 4Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 5Hamon Center for Therapeutic Oncology Research, 6Simmons Comprehensive Cancer Center, 7Department of Internal Medicine, 8Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA JDM receives licensing fees for lung cancer lines from the NIH and UT Southwestern. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.13.249029; this version posted August 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT Lineage-defining transcription factors (LTFs) play key roles in tumor cell growth, making them highly attractive, but currently “undruggable”, small cell lung cancer (SCLC) vulnerabilities.
    [Show full text]
  • Establishment of a Long-Term Stable Β-Cell Line and Its
    www.nature.com/scientificreports OPEN Establishment of a long‑term stable β‑cell line and its application to analyze the efect of Gcg expression on insulin secretion Satsuki Miyazaki1, Fumi Tashiro1, Takashi Tsuchiya2, Kazuki Sasaki2,4 & Jun‑ichi Miyazaki3* A pancreatic β‑cell line MIN6 was previously established in our lab from an insulinoma developed in an IT6 transgenic mouse expressing the SV40 T antigen in β‑cells. This cell line has been widely used for in vitro analysis of β‑cell function, but tends to lose the mature β‑cell features, including glucose‑ stimulated insulin secretion (GSIS), in long‑term culture. The aim of this study was to develop a stable β‑cell line that retains the characteristics of mature β‑cells. Considering that mice derived from a cross between C3H and C57BL/6 strains are known to exhibit higher insulin secretory capacity than C57BL/6 mice, an IT6 male mouse of this hybrid background was used to isolate insulinomas, which were independently cultured. After 7 months of continuous culturing, we obtained the MIN6‑CB4 β‑cell line, which stably maintains its GSIS. It has been noted that β‑cell lines express the glucagon (Gcg) gene at certain levels. MIN6‑CB4 cells were utilized to assess the efects of diferential Gcg expression on β‑cell function. Our data show the functional importance of Gcg expression and resulting basal activation of the GLP‑1 receptor in β‑cells. MIN6‑CB4 cells can serve as an invaluable tool for studying the regulatory mechanisms of insulin secretion, such as the GLP‑1/cAMP signaling, in β‑cells.
    [Show full text]
  • Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed
    Page 1 of 58 Diabetes DB16-0887 Mafa enables Pdx1 to effectively convert pancreatic islet progenitors and committed islet ααα-cells into βββ-cells in vivo Taka-aki Matsuoka1,***, Satoshi Kawashima1, Takeshi Miyatsuka1,2, Shugo Sasaki1, Naoki Shimo1, Naoto Katakami1, Dan Kawamori1, Satomi Takebe1, Pedro L. Herrera3, Hideaki Kaneto4, Roland Stein5, Iichiro Shimomura1 1 Department of Metabolic Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan 2 Center for Molecular Diabetology, Juntendo University Graduate School of Medicine, Tokyo, Japan 3 Department of Genetic Medicine and Development, University of Geneva Faculty of Medicine, CH-1211 Geneva 4, Switzerland 4 Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Okayama, Japan 5 Department of Molecular Physiology & Biophysics, Vanderbilt University Medical School, 723 Light Hall, Nashville, TN 37232, U.S.A. *Corresponding author. Address: 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan Tel: 81-6-6879-3743 Fax: 81-6-6879-3739 e-mail: [email protected] Key words: islet α cells, β cells, transdifferentiation, Mafa, Pdx1, diabetes - 1 - Diabetes Publish Ahead of Print, published online February 21, 2017 Diabetes Page 2 of 58 Abstract Among the therapeutic avenues being explored for replacement of the functional islet β-cell mass lost in Type 1 diabetes (T1D), reprogramming of adult cell types into new β-cells has been actively pursued. Notably, mouse islet α-cells will transdifferentiate into β-cells under conditions of near β-cell loss, a condition similar to T1D. Moreover, human islet α-cells also appear to poised for reprogramming into insulin+ cells.
    [Show full text]
  • Beta Cell Adaptation to Pregnancy Requires Prolactin Action on Both
    www.nature.com/scientificreports OPEN Beta cell adaptation to pregnancy requires prolactin action on both beta and non‑beta cells Vipul Shrivastava1, Megan Lee1, Daniel Lee1, Marle Pretorius1, Bethany Radford1, Guneet Makkar1 & Carol Huang1,2,3* Pancreatic islets adapt to insulin resistance of pregnancy by up regulating β‑cell mass and increasing insulin secretion. Previously, using a transgenic mouse with global, heterozygous deletion of prolactin receptor (Prlr+/−), we found Prlr signaling is important for this adaptation. However, since Prlr is expressed in tissues outside of islets as well as within islets and prolactin signaling afects β‑cell development, to understand β‑cell‑specifc efect of prolactin signaling in pregnancy, we generated a transgenic mouse with an inducible conditional deletion of Prlr from β‑cells. Here, we found that β‑cell‑specifc Prlr reduction in adult mice led to elevated blood glucose, lowed β‑cell mass and blunted in vivo glucose‑stimulated insulin secretion during pregnancy. When we compared gene expression profle of islets from transgenic mice with global (Prlr+/−) versus β‑cell‑specifc Prlr reduction (βPrlR+/−), we found 95 diferentially expressed gene, most of them down regulated in the Prlr+/− mice in comparison to the βPrlR+/− mice, and many of these genes regulate apoptosis, synaptic vesicle function and neuronal development. Importantly, we found that islets from pregnant Prlr+/− mice are more vulnerable to glucolipotoxicity‑induced apoptosis than islets from pregnant βPrlR+/− mice. These observations suggest that down regulation of prolactin action during pregnancy in non‑β‑cells secondarily and negatively afect β‑cell gene expression, and increased β‑cell susceptibility to external insults.
    [Show full text]